We're using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you're agreeing to our use of cookies.

Find out more
For more information, go to

Improving the quality of life of people with joint pain by targeting the stress regulator FKBP51

Award Details

  • Principal Investigator
    Dr Sandrine Geranton
  • Type of grant
    ZZZ-Invited Research Award
  • Amount Awarded
  • Institute
    University College London
  • Location
  • Status
  • Start Date
  • Grant reference number
  • Condition
    Osteoarthritis, Knee pain

What are the aims of this research?
People living with joint pain often experience symptoms such as low mood, anxiety, fatigue and memory impairment, conditions that altogether significantly impact well-being, and quality of life. The aim of this study is to investigate a new treatment designed to reduce pain, and improve sleep, fatigue and mood-related disorders.

Why is this research important?
A significant number of people with arthritis live with severe pain that is not adequately managed with current treatments. But as mentioned above, persistent pain is not the only consequence of arthritis. The researchers will investigate the potential of the protein FKBP51 that regulates the stress pathways in the brain.

Previous research in mice has shown that blocking this protein with a drug has antidepressant-like effects, improves sleep, and reduces signs of pain in mice with an inflamed joint. In the study, they will use mice with arthritis to test whether blocking the protein FKBP51 can improve the quality of life that has been impaired by joint pain, and in turn improve joint health and inflammation.

How will the findings benefit patients?
There has not been much fundamental research into the mood, sleep and cognitive disorders associated with arthritis, and as such there is a lack of treatments available to alleviate them and improve a persons’ quality of life. This project has the potential to provide a better understanding of the mood, sleep and cognitive disorders as well as fatigue associated with joint pain. Importantly, this study could provide a new treatment approach that could improve a range of conditions often associated with arthritis. It may lead to clinical trials in people with arthritis, and in the future, new pain-relieving drugs based around the blockage of the protein FKBP51 could potentially be developed.

We're now

Versus Arthritis.

You're being taken through to our new website in order to finish your donation.

Thank you for your generosity.

For more information, go to
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.